Cleared Traditional

K921666 - CARDIAC THERAPHY SYSTEM SCP 900

K921666 is an FDA 510(k) clearance for CARDIAC THERAPHY SYSTEM SCP 900, manufactured by Ppg Hellige B.V.. The device is a Class 2 Cardiovascular device with product code LDD cleared through the Traditional 510(k) pathway after a 534-day FDA review.

K921666 · Ppg Hellige B.V. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1993
Decision
534d
Days
Class 2
Risk

K921666 is an FDA 510(k) clearance for the CARDIAC THERAPHY SYSTEM SCP 900. Classified as Dc-defibrillator, Low-energy, (including Paddles) (product code LDD), Class II - Special Controls.

Submitted by Ppg Hellige B.V. (Lenexa, US). The FDA issued a Cleared decision on September 23, 1993 after a review of 534 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Ppg Hellige B.V. devices

FDA 510(k) Submission Details - K921666

510(k) Number K921666 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 07, 1992
Decision Date September 23, 1993
Days to Decision 534 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
409d slower than avg
Panel avg: 125d · This submission: 534d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LDD Device Classification - Class 2, Special Controls

Product Code LDD Dc-defibrillator, Low-energy, (including Paddles)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LDD Dc-defibrillator, Low-energy, (including Paddles)

All 116
Devices cleared under the same product code (LDD) and FDA review panel - the closest regulatory comparables to K921666.
5200 ADULT SOLID GEL MULTI-FUNCTION ELECTRODES
K931803 · Zoll Medical Corp · Oct 1993
ZOLL D 5400 ADULT SOLID GEL DEFIBRILLATION ELECTRO
K931804 · Zoll Medical Corp · Oct 1993
ZOLL PD 5200C ADULT SOLID GEL MULTI-FUNCTION ELECT
K931805 · Zoll Medical Corp · Oct 1993
DPD DEFIBRILLATOR
K930548 · Medical Research Laboratories, Inc. · Jun 1993
LIFEPAK 10 DEFIBRILLATOR/MONITOR W/OPT PACEMAKER
K931053 · Physio-Control Corp. · May 1993
MARQUETTE SERIES 360 DEFIBRILLATOR
K921487 · Marquette Electronics, Inc. · Dec 1992